SAN
DIEGO, Aug. 9, 2022 /PRNewswire/
-- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine
technology innovation, focused on transforming spine surgery with
minimally disruptive, procedurally integrated solutions, today
announced the resignation of Massimo
Calafiore, executive vice president and chief commercial
officer, effective August 31, 2022,
to become the chief executive officer of a privately-held,
orthopedics technology company. Upon Mr. Calafiore's resignation,
his responsibilities will be reallocated among current members of
management while the Company aligns its commercial structure to its
long-term strategy.
"On behalf of the NuVasive team, I would like to thank Massimo
for his impact on our organization," said Chris Barry, chief executive officer. "He has
accomplished much during his tenure at NuVasive and we wish him
great success in his new opportunity."
Mr. Calafiore stated, "In my five years at NuVasive, I am very
proud of our collective work to transform surgery, advance care and
most importantly—change the lives of patients around the world.
NuVasive is an amazing company, and I'm excited to see what it will
accomplish through bringing world-class, innovative technology to
market."
About NuVasive
NuVasive, Inc. (NASDAQ:
NUVA) is the leader in spine technology innovation, with a mission
to transform surgery, advance care, and change lives. The Company's
less-invasive, procedurally integrated surgical solutions are
designed to deliver reproducible and clinically proven outcomes.
The Company's comprehensive procedural portfolio includes surgical
access instruments, spinal implants, fixation systems, biologics,
software for surgical planning, navigation and imaging solutions,
magnetically adjustable implant systems for spine and orthopedics,
and intraoperative neuromonitoring technology and service
offerings. With more than $1 billion in net
sales, NuVasive operates in more than 50 countries
serving surgeons, hospitals, and patients. For more information,
please visit www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements
included in this news release that are not a description of
historical facts are forward-looking statements that involve risks,
uncertainties, assumptions and other factors which, if they do not
materialize or prove correct, could
cause NuVasive's results to differ materially from
historical results or those expressed or implied by such
forward-looking statements. The potential risks and uncertainties
which contribute to the uncertain nature of these statements
include, among others, risks associated with acceptance of the
Company's surgical products and procedures by spine surgeons and
hospitals, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products, the
Company's ability to adequately manage inventory as it continues to
release new products, its ability to recruit and retain management
and key personnel, and the other risks and uncertainties described
in NuVasive's news releases and periodic filings with
the Securities and Exchange
Commission. NuVasive's public filings with
the Securities and Exchange Commission are available
at www.sec.gov. NuVasive assumes no obligation to
update any forward-looking statement to reflect events or
circumstances arising after the date on which it was
made.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nuvasive-announces-departure-of-chief-commercial-officer-301602679.html
SOURCE NuVasive, Inc.